# Task E08: Lead Optimization Screening Assays for ADMET and Safety Profiling

> **NIH NIH N01** · EUROFINS PANLABS, INC. · 2021 · $29,422

## Abstract

The Non-clinical Services for Development of Interventional Agents for Infectious Diseases program provides services to facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins. Services include: preclinical product development planning and evaluation; lead identification and development; chemistry and GMP manufacturing; in vitro and in vivo preclinical microbiological, safety, toxicology and pharmacokinetics.

## Key facts

- **NIH application ID:** 10440009
- **Project number:** 272201800007I-0-759302100001-2
- **Recipient organization:** EUROFINS PANLABS, INC.
- **Principal Investigator:** JACOB BODE
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $29,422
- **Award type:** —
- **Project period:** 2018-05-01 → 2025-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10440009

## Citation

> US National Institutes of Health, RePORTER application 10440009, Task E08: Lead Optimization Screening Assays for ADMET and Safety Profiling (272201800007I-0-759302100001-2). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10440009. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*